G0138 Medicaid Rate by State

Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga

15 state Medicaid programs publish a fee-for-service rate for G0138 (intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga), ranging from $106.49 in New Hampshire to $650.50 in Mississippi among rates on the same basis, with a median of 81.4% of the national Medicare amount.

Every state, kept current

Every code in every state: the Rates plan

$29 /mo, 7-day free trial

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: Physician across 47 states, 8,503 codes.

2026-11-19 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

15

Median % of Medicare

81.4%

Rate range, like rates

$106.49 - $650.50

G0138 rates in every publishing state

  • Arizona$180.96

    92.1% of Medicare, 2025

  • District of Columbia$184.30

    93.8% of Medicare, Prior auth: not required, 2026

  • Idaho$155.95

    79.4% of Medicare, Prior auth: required, 2026

  • Indiana$158.63

    80.8% of Medicare, 2026

  • Missouri$585.45

    hospital outpatient payment

    Prior auth: not required, 2026

  • Mississippi$650.50

    331.2% of Medicare, 2024

  • Montana$241.54

    123% of Medicare, 2026

  • New Hampshire$106.49

    54.2% of Medicare, Prior auth: not required, 2026

  • New Jersey$162.72

    82.9% of Medicare, Prior auth: not required, 2026

  • New Mexico$650.50

    hospital outpatient payment

    2026

  • Ohio$125.93

    64.1% of Medicare, 2026

  • Oregon$159.93

    derived from the state's method

    81.4% of Medicare, 2026

  • Texas$520.40

    265% of Medicare, 2024

  • Wisconsin$131.25

    66.8% of Medicare, 2024

  • West Virginia$125.90

    64.1% of Medicare, 2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related physician codes

All 136 codes from G0008 to G0659 or every physician code by number.

Frequently asked questions

How much does Medicaid pay for G0138?

15 state Medicaid programs publish a fee-for-service rate for G0138 (intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga), ranging from $106.49 in New Hampshire to $650.50 in Mississippi among rates on the same basis, with a median of 81.4% of the national Medicare amount. The full table on this page lists every publishing state's current rate.

Which state pays the most for G0138?

Mississippi publishes the highest Medicaid rate for G0138 at $650.50 (331.2% of the national Medicare amount). New Hampshire publishes the lowest at $106.49, among rates on the same basis; rentals and rates far from the other states' are in the table with their basis.

Does G0138 require prior authorization under Medicaid?

1 of the 15 publishing states flag G0138 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".